AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Befotrik 500mg Injection

Prescription Icon
Prescription Required

Marketer

Blubell Pharma

Salt Composition

Ceftriaxone (500mg)

Overview Befotrik 500mg Injection

Cephalosporin antibiotic Cefix 500mg Injection combats various bacterial infections. Its applications encompass meningitis, pneumonia, ear, urinary tract, skin and soft tissue, bone and joint, bloodstream, and heart infections. Prophylactically, it's used pre-surgery to prevent infection. Administered intravenously or intramuscularly by a healthcare provider, dosage is determined individually. Regular, evenly-spaced doses are crucial; complete the prescribed course regardless of symptom improvement to prevent relapse. Common side effects, generally mild, include diarrhea, rash, altered liver function test results, and atypical blood cell counts (e.g., eosinophilia, leukopenia, thrombocytopenia). Injection site redness or pain may occur. Report any persistent or bothersome side effects. Prior to treatment, disclose any antibiotic allergies, liver or kidney issues, and all other medications being taken, as interactions are possible.

Uses of Befotrik 500mg Injection

Combating Bacterial Infections

Major Benefits of Befotrik 500mg Injection:

This medication will be administered by your healthcare provider; self-medication is strongly discouraged.

Common Side effects of Befotrik 500mg Injection:

  • Diarrhea
  • Abnormal liver function tests
  • Rash
  • Increased white blood cell count (eosinophils)
  • Decreased white blood cell count
  • Low blood platelets

How to use Befotrik 500mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Befotrik 500mg Injection works:

The antibiotic injection Befotrik 500mg works by disrupting bacterial cell wall synthesis, thus eliminating bacteria through the destruction of their essential protective layer.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions from concomitant use of Befotrik 500mg Injection and alcohol.

PregnancyPregnancySAFE IF PRESCRIBED

The injectable medication Befotrik 500mg is considered safe for use during pregnancy. Research generally indicates minimal or negligible risk to the fetus.

Breast feedingBreast feedingCAUTION

Administering Befotrik 500mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.

DrivingDrivingUNSAFE

The 500mg Befotrik injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

The 500mg Befotrik Injection can be administered to patients with kidney disease without altering the dosage. Nonetheless, disclosure of any pre-existing kidney condition to your physician is advised.

LiverLiverCAUTION

Administering Befotrik 500mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Befotrik 500mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.

What if you forget to take Befotrik 500mg Injection :

Should you forget a Befotrik 500mg Injection, seek your physician's advice.

Facts to Know About Befotrik 500mg Injection

LabelValue
Type of Compound Extended-coverage cephalosporin antibiotics (including third- and fourth-generation agents)
Potential for Dependence None.
Type of Medication Agents against infection

FAQs on Befotrik 500mg Injection

Administering Befotrik 500mg Injection is safe when adhering to the prescribed dosage and treatment schedule determined by your physician. Strictly follow the outlined regimen; do not omit any injection. Closely observe your doctor's guidance and report any concerning adverse reactions.
The onset of action for a 500mg Befotrik injection is typically rapid. Complete eradication of bacteria and resolution of symptoms, however, might require several days.
Patients with a known allergy to Befotrik 500mg Injection or its components should not receive this medication. Pre-existing liver, kidney, gallbladder, or hematological conditions, including hemolytic anemia, must be disclosed to the physician before administration. The use of Befotrik 500mg Injection during pregnancy, breastfeeding, or when planning pregnancy requires prior medical consultation to mitigate potential risks to the infant. Complete disclosure of all concurrent medications is crucial, as drug interactions are possible.
Contact your physician if your condition doesn't improve after completing the prescribed medication regimen. Similarly, report any worsening symptoms to your doctor while taking this medication.
The typical elimination half-life of a 500mg Befotrik injection is approximately 48 hours.
The 500mg Befotrik injection achieves optimal results when administered as directed by your physician. Continue treatment as prescribed, even with noticeable symptom improvement. Premature discontinuation of Befotrik 500mg Injection may lead to symptom recurrence or exacerbation.
Administering the Befotrik 500mg Injection requires the guidance of a qualified medical professional; self-injection is strictly prohibited. Dosage is determined by your physician based on your specific medical needs. To optimize treatment outcomes with Befotrik 500mg Injection, adhere precisely to your doctor's prescribed regimen.
Befotrik 500mg Injection
45
MRP 52
13% off